Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
October 23, 2018 08:00 ET
|
Neos Therapeutics, Inc.
Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options Development Strategy Leverages Neos’ Modified-Release...
Neos Therapeutics to Present at the Cantor Global Healthcare Conference
September 26, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Neos Therapeutics to Present at the Wells Fargo Healthcare Conference
August 29, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Neos Therapeutics to Host Second Quarter 2018 Financial Results Conference Call on August 8, 2018
August 01, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Appoints Jerry McLaughlin as Chief Executive Officer
June 27, 2018 16:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, June 27, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Participate in Two June Conferences
May 31, 2018 16:05 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the UBS Global Healthcare Conference
May 15, 2018 08:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports First Quarter 2018 Financial Results
May 09, 2018 07:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, May 09, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
March 15, 2018 07:00 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
March 08, 2018 07:30 ET
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...